Methyl (S)-5-amino-6-((oxetan-2-ylmethyl)amino)picolinate, 98%, 250mg

6-Ethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine hydrochloride, 95%, 100mg

Methyl 2-((R)-(3-chlorophenyl)((R)-piperidin-3-yl)methoxy)ethylcarbamate (2,2,2-trifluoroacetate), 98%, 100mg

4-metil-3-nitroanilina, mínimo 99 %, para síntesis, 25 g, envase de vidrio

3-methyl-3-pyrrolidinecarboxylic acid, 95.0%, 5g

2,4,4,5,5-Pentamethyl-1,3,2-dioxaborolane>98.0%(GC)5g

Invertase Solution50g

n-[(oxolan-2-yl)methyl]morpholine-4-carboxamide, 97%, 500mg

2-(4-Methoxyphenyl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 98%, 1g

2,2,2-Trifluoro-N-isopropylacetamide, 98%, 5g

2-Fluoro-6-methoxyaniline, 95.0%, 100g

1-(6-(Trifluoromethyl)pyridin-2-yl)ethanone, 97.0%, 250mg

tert-Butyl (3,3-dimethylpiperidin-4-yl)carbamate, 95.0%, 5g